| Original language | English (US) |
|---|---|
| Pages (from-to) | 2433-2436 |
| Number of pages | 4 |
| Journal | Future Oncology |
| Volume | 14 |
| Issue number | 24 |
| DOIs | |
| State | Published - Oct 1 2018 |
Fingerprint
T-Lymphocyte Subsets
Immunotherapy
Neoplasms
Keywords
- CD8+ T cells
- Stemness
- Tumor immunotherapy
ASJC Scopus subject areas
- Oncology
- Cancer Research
Cite this
Wang, W., He, Y., & Wu, S. (2018). Harnessing the CD8+ T-cell subsets with stemness for tumor immunotherapy. Future Oncology, 14(24), 2433-2436. https://doi.org/10.2217/fon-2018-0238
Harnessing the CD8+ T-cell subsets with stemness for tumor immunotherapy. / Wang, Wei; He, Yukai; Wu, Sha.
In: Future Oncology, Vol. 14, No. 24, 01.10.2018, p. 2433-2436.Research output: Contribution to journal › Review article
Wang, W, He, Y & Wu, S 2018, 'Harnessing the CD8+ T-cell subsets with stemness for tumor immunotherapy', Future Oncology, vol. 14, no. 24, pp. 2433-2436. https://doi.org/10.2217/fon-2018-0238
Wang W, He Y, Wu S. Harnessing the CD8+ T-cell subsets with stemness for tumor immunotherapy. Future Oncology. 2018 Oct 1;14(24):2433-2436. https://doi.org/10.2217/fon-2018-0238
@article{8ab9a51e8b494ebcb5488a687c534202,
title = "Harnessing the CD8+ T-cell subsets with stemness for tumor immunotherapy",
keywords = "CD8+ T cells, Stemness, Tumor immunotherapy",
author = "Wei Wang and Yukai He and Sha Wu",
year = "2018",
month = "10",
day = "1",
doi = "10.2217/fon-2018-0238",
language = "English (US)",
volume = "14",
pages = "2433--2436",
journal = "Future Oncology",
issn = "1479-6694",
publisher = "Future Medicine Ltd.",
number = "24",
}
TY - JOUR
T1 - Harnessing the CD8+ T-cell subsets with stemness for tumor immunotherapy
AU - Wang, Wei
AU - He, Yukai
AU - Wu, Sha
PY - 2018/10/1
Y1 - 2018/10/1
KW - CD8+ T cells
KW - Stemness
KW - Tumor immunotherapy
UR - http://www.scopus.com/inward/record.url?scp=85054461381&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054461381&partnerID=8YFLogxK
U2 - 10.2217/fon-2018-0238
DO - 10.2217/fon-2018-0238
M3 - Review article
VL - 14
SP - 2433
EP - 2436
JO - Future Oncology
JF - Future Oncology
SN - 1479-6694
IS - 24
ER -